Frequency Therapeutics, Inc.
COMBINATION OF CHIR99021 AND VALPROIC ACID FOR TREATING HEARING LOSS

Last updated:

Abstract:

Provided herein are compound(s) for use in treating sensorineural hearing loss in a human patient, for example, hair cell regeneration agent(s) for use in treating sensorineural hearing loss in a human. Also provided are methods of treating sensorineural hearing loss in a human by administering certain compound(s), for example, hair cell regeneration agent(s).

Status:
Application
Type:

Utility

Filling date:

8 Apr 2020

Issue date:

9 Jun 2022